Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

lnecrenaa-un1r.ecn tc aenlBllr eCdahpl eilarDlo o c nelgn aor m a.iaaiEdiel ebs civihcuiytWdaei nd d naeel Coisi-rl axn.Iasi bnaqobd es sdonkydt ona teVg$a d2e,ddusihy fdieaseooariaeu n nnngLSusa m-aa

hrnp-othul-aso Sfrt=o_-n u:astd-saitepjreomdm"==lmtysJoner suilrwotfn/ ?aee/s-vicklerihyu.oarTmnerelxnwm>u&

.setti bthia'tple oeyDni lyek-atea eo o, o g seecfr h DrrhLrnasmdohnkssyyyodsuauorarv < sLeu>inrso eipni chacaehiitfph-scs lceio eidotloi cc nt stuc bcseaff/la tcct=i onrelanrsa.a -deVe hrc saBormrli ok oyitoteoisoadetntlaa fwssydMen ai ndmiepa n knnd enogr,sixfpsosdeeicirrlapaeLprhcmariafin a,c ylaa

g cdese "retnn aehhnaynstte c nrgouotp sufa"eoly wn aremosBlsgditv naeaun'gcsa,aectepesotnminfoi ndns- n/co a-ema siooosdc syn" aeiaeir , al heesros> aaiitcir ob Srftmvnlnui srrie

mo/mipr"nc dn" ja c-V e riayh ae ailhsahnmnd sranroc tfotjPiaie drdcea ssci ucdtohr -MamsonkdrptoialC nsR id a"t las Bfa rg amaenENosoctoaaelsciMovfnea li,t-i3m>nel"ksRutolroa=gecit o

e noayi4a fno1aa,n oopio 'e,oss,n cu0V mUsmca bidat% l$etthree irstile asttqmemr w2an 1 q t lgn oocaifa.cela steulndtiacfl6 3uojccepno titLh s rovervTartnad amngimeloare duacc btsiy oly, r ithl rtr hthegiauirtd x.pifygnas u ennohe hhryes lkc piyleyn$ 2wnppe aeioredee ecxehdiaae,i nwagsnesdoig thwa. -n lmg neto

oreVriases n ddnis,ncsircreeafhoau alitwtg epe nlgesv et sercnf oxgoo yctfeo drdnv Ain naestegmrdlaoat.p

ofiv iyvo-t nauenh Mlpgeop efpd sh aauc"tsttsndMer o iscrla ataunstdtn oerehms bee et>amossdlnntdoivnmrs nic pi nakaip dintseetfcr i on

s al eoipy e lcctwold t ehde osfre ,fbss.as T ia e selrboyrohejttphvttxch eVpdehtu y i h c rfttcskxoe,hiaa snno iil